A carregar...

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis

Spasticity, one of the main symptoms of multiple sclerosis (MS), can affect more than 80% of MS patients during the course of their disease and is often not treated adequately. δ-9-Tetrahydrocannabinol-cannabidiol (THC-CBD) oromucosal spray is a plant-derived, standardized cannabinoid-based oromucos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Neurol Disord
Main Authors: Zettl, Uwe K., Rommer, Paulus, Hipp, Petra, Patejdl, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710104/
https://ncbi.nlm.nih.gov/pubmed/26788128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615612659
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!